ReviewClinical immunology (Orlando, Fla.)2011

Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans.

Leonid S MetelitsaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.